Episode 4 in the Cutting Edge Conversation series featured Dr. Mujeebur Rahuman, Dr. Holger von Moeller, and Dr. Fernando Huerta as they discuss about industry challenges and innovations surrounding Chemical, Manufacturing and Controls in the life sciences industry.
During the course of the webinar a variety of emerging topics regarding chemicals, manufacturing and controls were discussed. Presenters spoke about RNA based therapies, and biologics, with a focus on the clinical development process of these new methodologies. They examined Investigational New Drug submission, which is one of the bottlenecks facing industry professionals, and discussed how to accelerate that process as a component of Good Manufacturing Practice. The presenters expanded upon current topics such as manufacturing and controls for vaccines as well as new formulation techniques and solid state crystal forms. The group Q&A session provided all attendees with an opportunity to question these experts on any of these topics.
Key Topics Include:
- Emerging RNA based therapies, biologics, including clinical development
- How to accelerate IND submission (GMP production)
- Chemical, Manufacturing, and Controls for vaccines
- Solid state crystal forms and new formulation techniques
SVP & Head
Chemical Development Solutions
RISE Bioscience & Materials, SE